市場調査レポート

世界の体外診断市場(臨床化学・免疫検定・糖尿病検査・血液検査・分子診断):産業分析・規模・シェア・成長率・予測

In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

発行 Transparency Market Research 商品コード 277693
出版日 ページ情報 英文 124 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
世界の体外診断市場(臨床化学・免疫検定・糖尿病検査・血液検査・分子診断):産業分析・規模・シェア・成長率・予測 In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
出版日: 2013年07月31日 ページ情報: 英文 124 Pages
概要

当レポートでは、全世界の各種の体外診断(IDV)市場について分析し、全体的な市場構造や促進・抑制要因、製品別・用途別・地域別および主要国(米国・中国・インド)の詳細な市場規模動向(過去3年間の実績値と今後6年間の予測値)、競争環境、主要企業のプロファイル(企業・財務概要、事業戦略、製品構成、近年の動向)などを調査して、その結果を概略以下の構成でお届けします。

第1章 序論

第2章 エグゼクティブ・サマリー

第3章 市場概要

  • 市場動向と将来展望
    • 世界の体外診断市場(通算9年間分)
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • ポーターのファイブフォース分析
  • 市場の誘因性の分析:地域別

第4章 製品別市場(質的情報)

  • 概要
  • 臨床化学
  • 免疫検定
  • 糖尿病検査
  • 血液検査
  • 分子診断
  • その他

第5章 地域別市場(通算9年間分)

  • 概要
  • 北米市場
  • 欧州市場
  • アジア太平洋地域市場
  • 他の地域の市場

第6章 米国市場:製品別(通算9年間分)

  • 概要
  • 臨床化学用体外診断
  • 免疫検定用体外診断
  • 糖尿病検査用体外診断
  • 血液検査用体外診断
  • 分子診断用体外診断
  • その他の体外診断

第7章 中国市場:製品別(通算9年間分)

  • 概要
  • 臨床化学用体外診断
  • 免疫検定用体外診断
  • 糖尿病検査用体外診断
  • 血液検査用体外診断
  • 分子診断用体外診断
  • その他の体外診断

第8章 インド市場:製品別(通算9年間分)

  • 概要
  • 臨床化学用体外診断
  • 免疫検定用体外診断
  • 糖尿病検査用体外診断
  • 血液検査用体外診断
  • 分子診断用体外診断
  • その他の体外診断

第9章 競争環境

  • 主要企業の市場シェア

第10章 企業プロファイル

  • Abbott Laboratories Inc.
  • Alere, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Beckman Coulter, Inc.
  • Gen-Probe Incorporated
  • Johnson and Johnson
  • Life Technologies Corporation
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.

図表一覧

目次

In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 - 2018, keeping 2011 as the base year.

The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:

  • Market by Products
    • U.S.
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • India
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • China
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
  • Market by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Research Methodology
  • 1.3. Market Segmentation

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Market Trend and Future Outlook
    • 3.1.1 Global In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • 3.2. Market Dynamics
    • 3.2.1. Market drivers
      • 3.2.1.1. Rising Number of Patients with Infectious and Chronic Diseases
      • 3.2.1.2. Increasing Global Healthcare Expenditure
      • 3.2.1.3. Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools & Techniques
      • 3.2.1.4. Impact Analysis of the Market Drivers
    • 3.2.2. Market Restraints
      • 3.2.2.1. Reimbursement Challenges Retards the Growth of Market
      • 3.2.2.2. Uncertain and Ambiguous Regulatory environment restrains In Vitro Diagnostics market
      • 3.2.2.3. Impact Analysis of the Market Restraints
    • 3.2.3. Market Opportunities
      • 3.2.3.1. Molecular Diagnostics: Key to Future
      • 3.2.3.2. Epigenomics-Based Diagnostics expected to be an Emerging segment in In-Vitro Diagnostic Market
    • 3.2.4. Porter's Five Forces Analysis for In Vitro Diagnostic Market
      • 3.2.4.1. Bargaining Power of Suppliers
      • 3.2.4.2. Bargaining Power of Buyers
      • 3.2.4.3. Threat of new entrants
      • 3.2.4.4. Threat of substitutes
    • 3.2.5. Competitive rivalry
  • 3.3. Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography

Chapter 4 - Global In Vitro Diagnostics Market, by Products (Qualitative information)

  • 4.1. Overview
  • 4.2. Clinical Chemistry
  • 4.3. Immunoassay
  • 4.4. Diabetes Testing
  • 4.5. Blood Testing
  • 4.6. Molecular Diagnosis
  • 4.7. Others

Chapter 5 - Global In Vitro Diagnostics Market, by Geography

  • 5.1. Overview
  • 5.2. North America
    • 5.2.1. North America In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.5. Rest of the World
    • 5.5.1. ROW In Vitro Diagnostics Market, 2010-2018 USD Million)

Chapter 6 - U.S. In Vitro Diagnostics Market, by Products

  • 6.1. Overview
  • 6.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 6.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 6.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 6.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 6.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 6.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 7 - China In Vitro Diagnostics Market, by Products

  • 7.1. Overview
  • 7.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 7.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 7.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 7.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 7.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 7.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 8 - India In Vitro Diagnostics Market, by Products

  • 8.1. Overview
  • 8.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 8.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 8.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 8.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 8.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 8.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 9 - Competitive Landscape

  • 9.1. Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)

Chapter 10 - Company Profiles

  • 10.1. Abbott Laboratories Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial overview
    • 10.1.3. Business Strategies
    • 10.1.4. Product Portfolio
    • 10.1.5. Recent Developments
  • 10.2. Alere, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Overview
    • 10.2.3. Business Strategies
    • 10.2.4. Product Portfolio
    • 10.2.5. Recent Developments
  • 10.3. Bayer AG
    • 10.3.1. Company Overview
    • 10.3.2. Financial Overview
    • 10.3.3. Business Strategies
    • 10.3.4. Product Portfolio
    • 10.3.5. Recent Developments
  • 10.4. Becton, Dickinson and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Overview
    • 10.4.3. Business Strategies
    • 10.4.4. Product Portfolio
    • 10.4.5. Recent Developments
  • 10.5. Biomerieux SA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Overview
    • 10.5.3. Business Strategies
    • 10.5.4. Product Portfolio
    • 10.5.5. Recent Developments
  • 10.6. Beckman Coulter, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial overview
    • 10.6.3. Business Strategies
    • 10.6.4. Product portfolio
    • 10.6.5. Recent developments
  • 10.7. Gen-Probe Incorporated
    • 10.7.1. Company Overview
    • 10.7.2. Financial Overview
    • 10.7.3. Business Strategies
    • 10.7.4. Product Portfolio
    • 10.7.5. Recent Developments
  • 10.8. Johnson and Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Overview
    • 10.8.3. Business Strategies
    • 10.8.4. Product Portfolio
    • 10.8.5. Recent Developments
  • 10.9. Life Technologies Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Overview
    • 10.9.3. Business Strategies
    • 10.9.4. Product Portfolio
    • 10.9.5. Recent Developments
  • 10.10. F. Hoffmann-La Roche Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Overview
    • 10.10.3. Business strategies
    • 10.10.4. Product portfolio
    • 10.10.5. Recent developments
  • 10.11. Siemens Healthcare
    • 10.11.1. Company Overview
    • 10.11.2. Financial Overview
    • 10.11.3. Business Strategies
    • 10.11.4. Product Portfolio
    • 10.11.5. Recent Developments
  • 10.12. Thermo Fisher Scientific, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial overview
    • 10.12.3. Business strategies
    • 10.12.4. Product portfolio
    • 10.12.5. Recent developments

List of Figures

  • FIG. 1: Market Segmentation for the In Vitro Diagnostics Market
  • FIG. 2: Global In Vitro Diagnostics Market, U.S., 2011 (USD Million)
  • FIG. 3: Global In Vitro Diagnostics Market, China., 2011 (USD Million)
  • FIG. 4: Global In Vitro Diagnostics Market, India, 2011 (USD Million)
  • FIG. 5: Global In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 6: Total Healthcare Expenditure, Per Capita ( in USD)
  • FIG. 7: Porter's Five Forces Analysis for In Vitro Diagnostic Market
  • FIG. 8: Market Attractiveness Analysis of the Microscopy Devices Market, by geography
  • FIG. 9: Comparative Analysis of the Global IVD Market, by Geography, 2011 & 2018 (%)
  • FIG. 10: N. America In Vitro Diagnostics Market , 2010 - 2018 (USD Million)
  • FIG. 11: Europe In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 12: Asia Pacific In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 13: RoW In Vitro Diagnostics Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 14: Comparative Analysis of the U.S. In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 15: Clinical Chemistry IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 16: Immunoassay IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 17: Diabetes IVD Market, U.S., Market, 2010 - 2018 (USD Million)
  • FIG. 18: Blood Testing IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 19: Molecular Diagnosis IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 20: Other IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 21: Comparative Analysis of the China In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 22: Clinical Chemistry IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 23: Immunoassay IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 24: Diabetes IVD Market, China, Market, 2010 - 2018 (USD Million)
  • FIG. 25: Blood Testing IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 26: Molecular Diagnosis IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 27: Other IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 28: Comparative Analysis of the Indian In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 29: Clinical Chemistry IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 30: Immunoassay IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 31: Diabetes testing IVD Market, India, Market, 2010 - 2018 (USD Million)
  • FIG. 32: Blood Testing IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 33: Molecular Diagnosis IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 34: Other IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 35: Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
  • FIG. 36: Annual Revenue of Abbott Laboratories Inc., Diagnostics Division, 2010 - 2012 (USD million)
  • FIG. 37: Annual Revenue of Alere Inc., 2009- 2011 (USD million)
  • FIG. 38: Annual Sales of Bayer Healthcare, a division of Bayer AG, 2010-2012 (USD million)
  • FIG. 39: Annual revenue of BD Company, 2010 - 2012 (USD million)
  • FIG. 40: Annual revenue of BioMerieux SA, 2010 - 2012 (USD million)
  • FIG. 41: Annual revenue of Beckman Coulter, Inc., 2009 - 2010 (USD million)
  • FIG. 42: Annual revenue of Gen-Probe, Inc., 2010 - 2012 (USD Million)
  • FIG. 43: Annual revenue of Johnson and Johnson, Medical Devices an d Diagnostics Segment , 2010 - 2012 (USD Million)
  • FIG. 44: Annual revenue of Life Technologies Corporation, 2010 - 2012 (USD Million)
  • FIG. 45: Annual revenue of Roche Diagnostics, division of Roche Holdings, 2010 - 2012 (USD Million)
  • FIG. 46: Annual Revenue of Siemens Healthcare, 2009-2011 (USD million)
  • FIG. 47: (Conversion rate: 1 Euro = 1.33 USD)
  • FIG. 48: Annual revenue of Thermo Fisher Scientific, Inc., 2010 - 2012 (USD million)

List of Tables

  • TABLE 1: Market Snapshot: Global In Vitro Diagnostics Market
  • TABLE 2: Impact Analysis of the Market Drivers for In-Vitro Diagnostics Market
  • TABLE 3: Impact Analysis of the Market Restraints for Stem Cells Market
  • TABLE 4: Global IVD Market, by Geography, 2010 - 2018 (USD Million)
  • TABLE 5: U.S. IVD Market, by Products, 2010 - 2018 (USD Million)
  • TABLE 6: China IVD Market, by Products, 2010 - 2018 (USD Million)
  • TABLE 7: Indian IVD Market, by Products, 2010 - 2018 (USD Million)
Back to Top